Background: Postoperative nausea and vomiting (PONV) is a frequently encountered complication following general anaesthesia. Despite advances in anaesthetic techniques and antiemetic prophylaxis, PONV continues to contribute to patient discomfort, delayed recovery, prolonged post-anaesthesia care, and reduced patient satisfaction. Its occurrence is influenced by patient characteristics, anaesthetic agents, surgical factors, and postoperative analgesic requirements. Aim: To determine the incidence, severity, associated risk factors, and clinical outcomes of postoperative nausea and vomiting among adult patients undergoing elective surgery under general anaesthesia. Materials and Methods: A prospective observational study is proposed in the Department of Anaesthesiology, Mamata Medical College, Khammam. Adult patients undergoing elective surgical procedures under general anaesthesia will be consecutively enrolled. Demographic characteristics, smoking status, previous history of PONV or motion sickness, anaesthetic technique, surgical duration, perioperative opioid administration, and antiemetic prophylaxis will be documented. Episodes of nausea, retching, and vomiting will be assessed during the first 24 postoperative hours. The simplified Apfel risk score will be calculated, and associations between potential predictors and PONV will be evaluated using appropriate statistical methods. Results: The study will assess the cumulative incidence of PONV within 24 hours, the timing and severity of symptoms, the distribution of Apfel risk scores, requirements for rescue antiemetic medication, and the relationship between PONV and selected perioperative variables. Numerical results will be reported following analysis of original patient records. Conclusion: Systematic assessment of postoperative nausea and vomiting may help identify patients at increased risk and evaluate the effectiveness of existing perioperative prevention and management practices. Institution-specific findings may support the development of risk-adapted antiemetic strategies and improved postoperative recovery protocols.
Postoperative nausea and vomiting (PONV) remains one of the most frequently reported and distressing complications of general anaesthesia. Although advances in anaesthetic techniques, pharmacological prophylaxis, and postoperative care have improved perioperative safety, PONV continues to affect a substantial proportion of surgical patients. The condition is characterized by nausea, retching, or vomiting following an operative procedure and is usually evaluated during the first 24 postoperative hours. Its occurrence can delay recovery, increase patient discomfort, interfere with oral intake, and contribute to prolonged hospital observation. Gan et al., in the Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting, emphasized the continuing importance of risk assessment, multimodal prophylaxis, and appropriate rescue treatment [1].
The development of PONV is multifactorial, involving interactions between patient-specific susceptibility, anaesthetic medications, surgical duration, and postoperative analgesia. Individual susceptibility varies considerably, and certain clinical characteristics have consistently been identified as independent predictors. Apfel et al. developed a simplified risk score incorporating four factors: female sex, history of PONV or motion sickness, nonsmoking status, and postoperative opioid administration [2]. The model demonstrated progressively increasing PONV risk as the number of predictors increased, providing a practical tool for preoperative risk assessment and perioperative management.
A prospective survey conducted by Koivuranta et al. evaluated postoperative nausea and vomiting among 1,107 patients and identified several important associated factors, including female sex, previous postoperative sickness, motion sickness, longer duration of surgery, and nonsmoking status [3]. The study demonstrated that postoperative nausea and vomiting may occur at different stages of recovery, highlighting the importance of follow-up beyond the immediate post-anaesthesia period.
The role of anaesthetic agents is also important in the development of postoperative emetic symptoms. Volatile anaesthetic agents and postoperative opioid administration have been associated with increased PONV risk, whereas propofol-based total intravenous anaesthesia may reduce early postoperative nausea and vomiting in appropriately selected patients. In a systematic review and evidence-based analysis, Apfel et al. identified female sex, previous PONV or motion sickness, nonsmoking status, younger age, volatile anaesthetic exposure, longer duration of anaesthesia, and postoperative opioids as relevant independent predictors [4].
The clinical significance of PONV extends beyond transient discomfort. Repeated vomiting may contribute to dehydration, electrolyte abnormalities, wound discomfort, and interruption of postoperative recovery. In some surgical populations, vomiting may be particularly undesirable because of increased pressure on operative sites or the risk of aspiration. Patients affected by severe symptoms may require additional antiemetic medication, intravenous fluids, extended monitoring, or delayed discharge.
PONV also has implications for patient satisfaction and quality of recovery. The experience of nausea or vomiting after surgery may negatively influence patients' perceptions of anaesthetic care, even when the surgical procedure itself is uncomplicated. For this reason, prevention of PONV represents an important component of patient-centred perioperative management.
Current evidence-based approaches emphasize structured risk identification, reduction of modifiable risk factors, and prophylaxis using antiemetic agents with different mechanisms of action. The Fourth Consensus Guidelines recommend multimodal prophylaxis for patients with relevant risk factors and effective rescue therapy when symptoms occur despite preventive treatment [1]. Nevertheless, institutional practices may vary according to patient populations, resources, surgical case mix, and local protocols.
The actual incidence and clinical patterns of PONV in a particular hospital may differ from findings reported internationally. Consequently, institution-specific observational research may help identify gaps in existing prevention strategies and highlight areas for quality improvement.
The present study is therefore proposed to evaluate postoperative nausea and vomiting among adult patients undergoing general anaesthesia at Mamata Medical College, Khammam, with particular attention to incidence, symptom severity, associated risk factors, antiemetic practices, and recovery outcomes.
A prospective, hospital-based observational study will be conducted in the Department of Anaesthesiology, Mamata Medical College, Khammam, Telangana, India. The study will investigate the incidence, timing, severity, and associated factors of postoperative nausea and vomiting among adults undergoing elective surgery under general anaesthesia. The recruitment period will be predefined, and all participants will be followed for 24 hours after completion of surgery.
Study population
Adult patients aged 18 years and above scheduled for elective surgical procedures under general anaesthesia will be considered eligible. Consecutive recruitment will be used to reduce selection bias and improve representation of the routine surgical population.
Inclusion criteria: Adult patients undergoing elective surgery under general anaesthesia who can provide informed consent and reliably report postoperative symptoms.
Exclusion criteria: Patients with ongoing preoperative nausea or vomiting, individuals unable to provide reliable postoperative symptom assessments, and patients requiring prolonged postoperative mechanical ventilation or deep sedation that prevents evaluation within the designated follow-up period.
Preoperative evaluation
Demographic and clinical information will be recorded using a structured data collection form. Variables will include age, sex, body mass index, smoking status, ASA physical status, previous history of postoperative nausea and vomiting, and history of motion sickness.
The simplified Apfel score will be calculated using four established predictors: female sex, nonsmoking status, previous PONV or motion sickness, and planned postoperative opioid use. Actual postoperative opioid administration will also be documented. The distinction between planned and administered opioids will be maintained during analysis.
Intraoperative data collection
Intraoperative information will include surgical specialty, type and duration of procedure, anaesthetic induction and maintenance agents, exposure to volatile anaesthetics and nitrous oxide, opioid administration, intravenous fluid therapy, and antiemetic prophylaxis.
The study will be observational, and anaesthetic management will be determined by the treating anaesthesiologist according to clinical judgment and institutional protocols. No prophylactic antiemetic treatment will be withheld for research purposes.
Postoperative assessment
Postoperative nausea and vomiting will be assessed at standardized time intervals: 0–2 hours, more than 2–6 hours, and more than 6–24 hours after surgery.
Nausea will be defined as the subjective unpleasant sensation associated with an urge to vomit. Vomiting will be defined as active expulsion of gastric contents, and retching will be recorded separately when present.
Nausea severity will be measured using a numerical rating scale from 0 to 10, with higher scores indicating more severe symptoms. The timing and number of vomiting episodes will be documented. Rescue antiemetic administration, postoperative opioid exposure, and relevant recovery outcomes will also be recorded.
Outcome measures
The primary outcome will be the cumulative proportion of participants experiencing at least one episode of nausea, retching, or vomiting during the first 24 postoperative hours.
Secondary outcomes will include isolated nausea, vomiting incidence, symptom severity, timing of events, rescue antiemetic requirements, Apfel risk-score distribution, and associations with perioperative variables.
Statistical analysis
Data will be analysed using appropriate statistical software. Categorical variables will be presented as counts and percentages, while continuous variables will be summarized using means and standard deviations or medians and interquartile ranges.
Associations between PONV and selected risk factors will initially be examined using chi-square or Fisher's exact tests. Multivariable logistic regression will be considered to identify independently associated factors. Adjusted odds ratios and 95% confidence intervals will be reported.
The number of variables included in regression models will be limited according to the number of observed outcome events. Statistical significance will be defined as a two-sided p-value below 0.05.
The following tables provide a structured format for the proposed study results. All values marked Pending must be completed using actual clinical observations.
Table 1. Demographic and perioperative characteristics
|
Characteristic |
Number / Mean ± SD |
Percentage (%) |
|
Age 18–30 years |
Pending |
Pending |
|
Age 31–45 years |
Pending |
Pending |
|
Age 46–60 years |
Pending |
Pending |
|
Age above 60 years |
Pending |
Pending |
|
Male |
Pending |
Pending |
|
Female |
Pending |
Pending |
|
ASA physical status I |
Pending |
Pending |
|
ASA physical status II |
Pending |
Pending |
|
ASA physical status III or higher |
Pending |
Pending |
|
Duration of surgery, minutes |
Pending |
— |
|
Total participants |
Pending |
100 |
Table 1 will summarize the demographic and perioperative characteristics of patients undergoing general anaesthesia. Age, sex, and ASA physical status will help characterize the study population and support comparisons with previous research. The duration of surgery will be analysed as a continuous variable because prolonged anaesthetic exposure may be associated with increased PONV risk.
Table 2. Incidence of postoperative nausea and vomiting during the first 24 hours
|
Outcome |
Number of patients |
Percentage (%) |
|
Any PONV within 24 hours |
Pending |
Pending |
|
Nausea within 24 hours |
Pending |
Pending |
|
Retching within 24 hours |
Pending |
Pending |
|
Vomiting within 24 hours |
Pending |
Pending |
|
No PONV |
Pending |
Pending |
|
Rescue antiemetic required |
Pending |
Pending |
Table 2 will present the overall postoperative incidence of nausea, retching, and vomiting. Patients may experience more than one type of symptom, and therefore the individual symptom categories may overlap. The primary outcome will be the proportion of patients experiencing any PONV within the first 24 postoperative hours. The percentage of patients requiring rescue antiemetics will provide additional information about the clinical impact of symptoms.
Table 3. Distribution of postoperative nausea and vomiting according to observation period
|
Postoperative period |
Nausea n (%) |
Retching n (%) |
Vomiting n (%) |
|
0–2 hours |
Pending |
Pending |
Pending |
|
More than 2–6 hours |
Pending |
Pending |
Pending |
|
More than 6–24 hours |
Pending |
Pending |
Pending |
This table will identify the postoperative periods during which emetic symptoms are most frequently observed. Early PONV may be influenced by anaesthetic exposure and immediate recovery factors, while later symptoms may be associated with postoperative analgesia, oral intake, and individual susceptibility. Patients may experience symptoms during multiple intervals and should be counted separately in each applicable time window.
Table 4. Postoperative nausea and vomiting according to Apfel risk score
|
Apfel score |
Total patients |
Patients with PONV n (%) |
Patients without PONV n (%) |
|
0 |
Pending |
Pending |
Pending |
|
1 |
Pending |
Pending |
Pending |
|
2 |
Pending |
Pending |
Pending |
|
3 |
Pending |
Pending |
Pending |
|
4 |
Pending |
Pending |
Pending |
|
Total |
Pending |
Pending |
Pending |
Table 4 will evaluate the relationship between the simplified Apfel risk score and observed postoperative nausea and vomiting. Higher scores would be expected to correspond to greater baseline susceptibility based on previous research, but this relationship must be assessed using the actual study data. For each score category, the percentage experiencing PONV should be calculated using the number of patients in that category as the denominator.
Table 5. Association between selected perioperative factors and PONV
|
Potential risk factor |
PONV present n/N (%) |
PONV absent n/N (%) |
p-value |
|
Female sex |
Pending |
Pending |
Pending |
|
Nonsmoking status |
Pending |
Pending |
Pending |
|
Previous history of PONV |
Pending |
Pending |
Pending |
|
History of motion sickness |
Pending |
Pending |
Pending |
|
Volatile anaesthetic exposure |
Pending |
Pending |
Pending |
|
Postoperative opioid administration |
Pending |
Pending |
Pending |
|
Anaesthesia duration above 120 minutes |
Pending |
Pending |
Pending |
Table 5 will examine associations between established or clinically relevant risk factors and postoperative nausea and vomiting. Unadjusted comparisons will be followed by multivariable analysis where feasible. The observational study design requires caution because associations may be affected by confounding factors, differences in prophylactic treatment, and surgical case mix.
Table 6. Severity of postoperative nausea
|
Maximum nausea score |
Classification for this study |
Number of patients |
Percentage (%) |
|
0 |
No nausea |
Pending |
Pending |
|
1–3 |
Mild nausea |
Pending |
Pending |
|
4–6 |
Moderate nausea |
Pending |
Pending |
|
7–10 |
Severe nausea |
Pending |
Pending |
Table 6 will describe maximum postoperative nausea severity according to the numerical rating scale. The mild, moderate, and severe categories are operational definitions selected for this study and should be finalized in the protocol. This assessment will help distinguish mild transient symptoms from more clinically burdensome episodes requiring additional treatment.
Table 7. Antiemetic prophylaxis and rescue treatment
|
Treatment characteristic |
Number of patients |
Percentage (%) |
|
No documented prophylactic antiemetic |
Pending |
Pending |
|
Single-agent prophylaxis |
Pending |
Pending |
|
Two-agent prophylaxis |
Pending |
Pending |
|
Three or more prophylactic agents |
Pending |
Pending |
|
Rescue antiemetic administered |
Pending |
Pending |
|
Repeat rescue treatment required |
Pending |
Pending |
|
Persistent symptoms despite rescue treatment |
Pending |
Pending |
Explanation: This table will evaluate the antiemetic prevention and management practices used during the perioperative period. Prophylaxis categories should be reported separately from rescue-treatment outcomes. Because patients at higher baseline risk may receive more intensive prophylaxis, comparisons of PONV rates between treatment groups must account for confounding by indication.
Postoperative nausea and vomiting continues to represent an important challenge in anaesthetic practice despite developments in perioperative pharmacology and enhanced recovery protocols. The condition is associated with patient discomfort, delayed recovery, increased requirements for supportive treatment, and reduced satisfaction with anaesthetic care. The proposed study aims to evaluate the incidence, clinical characteristics, and associated factors of PONV among patients undergoing general anaesthesia in a tertiary care hospital. Although institution-specific findings are not yet available, existing research provides a useful framework for evaluating the anticipated outcomes.
Gan et al. published the Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting in 2020 [1]. These recommendations emphasize systematic risk identification, reduction of modifiable risk factors, multimodal prophylaxis, and appropriate rescue therapy. The guidelines recognize that PONV remains common even when preventive interventions are available and recommend structured institutional approaches to improve patient outcomes. The proposed observational study may help determine whether routine perioperative practices adequately address the PONV risk characteristics observed in the local population.
The simplified Apfel score remains an important clinical tool for predicting PONV risk. Apfel et al. identified four major predictors: female sex, previous PONV or motion sickness, nonsmoking status, and postoperative opioid use [2]. Their original validation demonstrated progressively higher PONV incidence with increasing numbers of risk factors. Patients with no predictors had an estimated incidence of approximately 10%, compared with approximately 79% among those with all four factors in the studied populations. However, these historical risk estimates may not precisely reflect current outcomes because anaesthetic approaches and antiemetic prophylaxis have evolved.
Koivuranta et al. conducted a prospective survey involving 1,107 surgical patients and documented the clinical importance of monitoring nausea and vomiting throughout postoperative recovery [3]. Their findings identified female sex, previous postoperative sickness, motion sickness, longer surgical duration, and nonsmoking status as relevant predictive factors. The study also demonstrated that nausea and vomiting may occur beyond the immediate recovery period. Accordingly, the proposed investigation will assess symptoms during the first 24 hours after surgery rather than limiting evaluation to the post-anaesthesia care unit.
A systematic review by Apfel et al. examined risk factors using data from 22 studies involving more than 95,000 patients [4]. Female sex was the strongest patient-related predictor identified in the analysis, while previous PONV, motion sickness, and nonsmoking status were also associated with increased risk. Among anaesthesia-related exposures, volatile anaesthetics, longer anaesthetic duration, and postoperative opioids were important predictors. These findings support the collection of both patient-specific and perioperative variables within the proposed study.
Postoperative opioid administration deserves particular attention because opioids may contribute to nausea and vomiting through central and gastrointestinal mechanisms. At the same time, adequate postoperative analgesia is essential for patient comfort and recovery. Therefore, opioid-sparing multimodal analgesia may provide benefits beyond pain control, although the effectiveness of individual strategies depends on surgical context and patient characteristics. Any association between opioid exposure and PONV in the proposed study should be interpreted after considering the indication and amount of opioid administration.
Antiemetic prophylaxis represents another important aspect of perioperative management. The Fourth Consensus Guidelines recommend the use of preventive interventions targeting multiple pathways in patients with relevant risk factors [1]. Commonly employed agents include serotonin 5-HT3 receptor antagonists, corticosteroids, and other antiemetics according to clinical suitability. Nevertheless, patients may develop symptoms despite prophylaxis, emphasizing the need for timely rescue treatment.
Several methodological limitations should be considered when interpreting the proposed study. The single-centre design may restrict generalizability, while the observational approach cannot establish causality. Differences in anaesthetic techniques, surgical procedures, and prophylactic antiemetic regimens may introduce confounding. Patient-reported nausea severity may also vary according to individual perceptions and postoperative communication ability.
Another important consideration is the distinction between nausea and vomiting. Nausea is a subjective experience, whereas vomiting can be observed and counted as an event. Combining these outcomes without separate reporting may obscure differences in clinical presentation and treatment needs. The proposed study will therefore report overall PONV incidence alongside separate nausea, retching, and vomiting outcomes.
Despite these limitations, prospective clinical assessment may provide meaningful information regarding institutional PONV patterns. Evaluation of symptom timing, severity, established risk scores, and rescue antiemetic requirements may support improved patient risk stratification and perioperative quality improvement.
The proposed study will assess the incidence, timing, severity, and associated factors of postoperative nausea and vomiting among patients undergoing elective surgery at Mamata Medical College, Khammam. The investigation will also evaluate the relationship between Apfel risk scores, antiemetic prophylaxis, and rescue treatment requirements. The findings may help identify opportunities to strengthen risk assessment, optimize antiemetic prophylaxis, and improve postoperative patient comfort. Conclusions regarding the actual frequency and predictors of PONV in the study population must be based on completed clinical data analysis.